Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

Systematic bone loss is commonly complicated with inflammatory bowel diseases (IBDs) with unclear pathogenesis and uncertain treatment. In experimental colitis mouse models established by dextran sulfate sodium and IL-10 knockout induced with piroxicam, bone mass and quality are significantly decrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiawei, Wang, Fuxiao, Hu, Yan, Luo, Ying, Wei, Yan, Xu, Ke, Zhang, Hao, Liu, Han, Bo, Lumin, Lv, Shunli, Sheng, Shihao, Zhuang, Xinchen, Zhang, Tao, Xu, Can, Chen, Xiao, Su, Jiacan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873828/
https://www.ncbi.nlm.nih.gov/pubmed/36603578
http://dx.doi.org/10.1016/j.xcrm.2022.100881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873828/
https://www.ncbi.nlm.nih.gov/pubmed/36603578
http://dx.doi.org/10.1016/j.xcrm.2022.100881

Ejemplares similares